236
Views
17
CrossRef citations to date
0
Altmetric
Retina and Choroid

Ocular Permeation and Sustained Anti-inflammatory Activity of Dexamethasone from Kaolin Nanodispersion Hydrogel System

, , , , &
Pages 828-838 | Received 15 Sep 2017, Accepted 25 Feb 2018, Published online: 09 Mar 2018

References

  • Carretero MI. Clay minerals and their beneficial effects upon human health. Review Appl Clay Sci. 2002;21:155–63.
  • Da Silva GR, Da Silva-Cunha A Jr, Behar-Cohen F, Ayres E, Orefice RL. Biodegradable polyurethane nanocomposites containing dexamethasone for ocular route. Mater Sci Eng C. 2011;31:414–22.
  • Suresh PK, Dewangan D. Ophthalmic delivery system for dexamethasone: an overview. Int J Innov Pharm Res. 2011;2(4):161–65.
  • Gordon DM. Dexamethasone in ophthalmology. Am J Ophthalmol. 1959;48:656–60.
  • Zignani M, Einmahl S, Baeyens V, Varesio E, Veuthey JL, Anderson J, Heller J, Tabatabay C, Gurny R. Poly(orthoester) designed for combined ocular delivery of dexamethasone sodium phosphate and 5-fluorouracil: sub conjunctival tolerance and in vitro release. Eur J Pharm Biopharm. 2000;50:251–55.
  • Shell JW. Ophthalmic drug delivery systems. Surv Ophthalmol. 1984;29:117–28.
  • Maurice DM, Mishima S. Pharmacology of the eye. In: Sears ML, editor. Ocular pharmacokinetics. Berlin: Springler-Verlag; 1984.
  • Cagini C, Cometa F, Torroni G, Pellegrino A, Pellegrino R. Dexamethasone disodium phosphate penetration into human aqueous humor after topical application. Curr Eye Res. 2016;41:897–99.
  • Short BG. Safety evaluation of ocular drug delivery formulations: techniques and practical considerations. Toxicol Pathol. 2008;36:49–62.
  • Osswald CR, Guthrie MJ, Avila A, Valio JAJ, Mieler WF, Kang-Mieler JJ. In vivo efficacy of an injectable microsphere-hydrogel ocular drug delivery system. Curr Eye Res. 2017;42:1293–301.
  • Dunn JP, Van Natta M, Foster G, Kuppermann BD, Martin FD, Zong A, Jabs DA. Complications of ganciclovir implant surgery in patients with cytomegalovirus retinitis: the ganciclovir cidofovir cytomegalovirus retinitis trial. Retina. 2004;24:41–50.
  • Ayar O, Alpay A, Koban Y, Akdemir MO, Yazgan S, Canturk Ugurbas S, Ugurbas SH. The effect of dexamethasone intravitreal implant on retinal nerve fiber layer in patients diagnosed with branch retinal vein occlusion. Curr Eye Res. 2017;42:1287–92.
  • Qi H, Chena W, Huang C, Li L, Chen C, Li W, Wu C. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin. Int J Pharm. 2007;337:178–87.
  • Li J, Wu L, Wu W, Wang B, Wang Z, Xin H, Xu Q. A potential carrier based on liquid crystal nanoparticles for ophthalmic delivery of pilocarpine nitrate. Int J Pharm. 2013;455:75–84.
  • Xu X, Khan MA, Burgess DJ. Predicting hydrophilic drug encapsulation inside unilamellar liposomes. Int J Pharm. 2012;423:410–18.
  • Rechichi M, Mazzotta C, Daya S, Mencucci R, Lanza M, Meduri A. Intraoperative OCT pachymetry in patients undergoing dextran-free riboflavin UVA accelerated corneal collagen crosslinking. Curr Eye Res. 2016;41(10):1310–15.
  • Kaur PI, Garg A, Singla KA, Aggarwal D. Vesicular systems in ocular drug delivery: an overview. Int J Pharm. 2004;269:1–14.
  • Sipai AM, Yadav V, Mamatha Y, Prasanth VV. Liposomes: an overview. J Pharm Sci Innov. 2012;1(1):13–21.
  • Hu XH, Li D. Facile way to synthesise hydrogel contact lenses with good performance for ophthalmic drug delivery. Mater Technol. 2013;28:192–98.
  • Das D, Pal S. Modified biopolymer-dextrin based crosslinked hydrogel: application in controlled drug delivery. RSC Adv. 2015;5:25014–50.
  • Osswald CR, Kang-Mieler JJ. Controlled and extended in vitro release of bioactive anti-vascular endothelial growth factors from a microsphere-hydrogel drug delivery system. Curr Eye Res. 2016;41:1216–22.
  • Saettone MF, Salminenb L. Ocular inserts for topical delivery. Adv Drug Deliv Rev. 1995;16:95–106.
  • Olphen VH. An introduction to clay colloid chemistry. New York: John Wiley and Sons; 1977.
  • Pinto FCH, Silva-Cunha A, Pianetti GA, Ayres E, Orefice RL, Silva GRD. Montmorillonite clay-based polyurethane nanocomposite as local triamcinolone acetonide delivery system. J Nanomater. 2011;2011:1–11.
  • Lagaly G, Ziesmer S. Colloid chemistry of clay minerals: the coagulation of montmorrilonite dispersions. Adv Colloid Interface Sci. 2003;100–102:105–28.
  • Swain K, Pattnaik S, Sahu SC, Patnaik KK, Mallick S. Drug in adhesive type transdermal matrix systems of ondansetron hydrochloride: optimization of permeation pattern using response surface methodology. J Drug Target. 2010;18:106–14.
  • Swain K, Pattnaik S, Sahu SC, Mallick S. Feasibility assessment of ondansetron hydrochloride transdermal systems: physicochemical characterization and in vitro permeation studies. Lat Am J Pharm. 2009;28:706–14.
  • Pattnaik S, Swain K, Bindhani A, Mallick S. Influence of chemical permeation enhancers on transdermal permeation of alfuzosin: an investigation using response surface modeling. Drug Dev Ind Pharm. 2011;37:465–74.
  • Mohapatra R, Senapati S, Sahoo C, Mallick S. Transcorneal permeartion of diclofenac as a function of temperature from film formulation in presence of triethanolamine and benzalkonium chloride. Colloids Surf B Biointerfaces. 2014;123:170–80.
  • Mohapatra R, Mallick S, Nanda A, Sahoo RN, Pramanik A, Bose A, Das D, Pattnaik L. Analysis of steady state and non-steady state corneal permeation of diclofenac. RSC Adv. 2016;6:31976–87.
  • Kato M, Hagiwara Y, Oda T, Imamura-Takai M, Aono H, Beneficial NM. 31pharmacological effects of selective glucocorticoid receptor agonist in external eye diseases. J Ocul Parmacol Ther. 2011;27(4):353–60.
  • Oka T, Shearer TR, Azuma M. Involvement of cyclooxygenase-2 in rat models of conjunctivitis. Curr Eye Res. 2004;29(1):27–34.
  • Shukr M. Formulation, in vitro and in vivo evaluation of lidocaine HCl ocular inserts for topical ocular anesthesia. Arch Pharm Res. 2014;37:882–89.
  • Calles JA, Tartara LI, Lopez-Garcia A, Diebold Y, Palma SD, Valles EM. Novel bioadhesive hyaluronan-itaconic acid crosslinked films for ocular therapy. Int J Pharm. 2013;455:48–56.
  • Mallick S, Gupta BK, Ghoshal SK. Development and characterization of release profile of nifedipine as an effective controlled release system. J Sci Ind Res. 58(1999):1010–16.
  • Mallick S, Sahu A, Pal K. Dissolution behavior of nalidixic acid solid dispersions using water-soluble dispersion carriers. Acta Pol Pharm. 2004;61:21–30.
  • Korsmeyer RW, Peppas NA. Effect of the morphology of hydrophilic polymeric matrices on the diffusion and release of water soluble drugs. J Membr Sci. 1981;9:211–27.
  • Mohapatra R, Mallick S. Transient and steady state characterization of permeation kinetics of diclofenac through oculat tissue. Asian J Chem. 2016;28(5):1149–54.
  • One-way ANOVA and multiple comparison in Excel tutorial, Addinsoft SARL, XLSTAT; 2017 [accessed 2017 Mar 01]. https://help.xlstat.com/customer/en/portal/articles/2062232 running a one way anova followed by multiple comparisons tests withxlstat?b_id¼9283.
  • Hu X, Gong X. A new route to fabricate biocompatible hydrogels with controlled drug delivery behavior. J Colloid Interface Sci. 2016;470:62–70.
  • Remington. The science and practice of pharmacy. Lippincott Williams & Wilkins. Vol. 1. 21st ed. New Delhi: Wolters Kluwer Health (India) Pvt. Ltd., 2005. p. 862.
  • Doile MM, Fortunato AK, Schmücker IC, Schucko SK, Silva MA, Rodrigues PO. Physicochemical properties and dissolution studies of dexamethasone acetate-β-cyclodextrin inclusion complexes produced by different methods. AAPS Pharm Sci Tech. 2008;9:314–21.
  • Schnitzler E, Carvalho MADS, Stadler CC, Volpato AM, Ionashiro M. Application of differential scanning calorimetry (DSC) in the thermal characterization of dexamethasone acetate, excipients and dexamethasone cream. Ecletica Quimica. 2000;26:41–52.
  • Panda BB, Subhadarsini R, Mallick S. Biointerfacial phenomena of amlodipine buccomucosal tablets of HPMC matrix system containing polyacrylate polymer/β-cyclodextrin: correlation of swelling and drug delivery performance. Expert Opin Drug Deliv. 2016;13:633–43.
  • Panyam J, Williams D, Dash A, Leslie-Pelecky D, Labhasetwar V. solid-state solubility influences encapsulation and release of hydrophobic drugs from PLGA/PLA nanoparticles. J Pharm Sci. 2004;93(7):1804–14.
  • Jojart-Laczkovich O, Szabo-Revesz P. Amorphization of a crystalline active pharmaceutical ingredient and thermpanalytical measurements on this glassy form. J Therm Anal Calorim. 2010;102:243–47.
  • Mallick S, Pattnaik S, Swain K, De PK, Saha A, Ghosal G, Mondal A. Formation of physically stable amorphous phase of ibuprofen by solid state milling with kaolin. Eur J Pharm Biopharm. 2008;68:346–51.
  • Panda B, Parihar AS, Mallick S. Effect of plasticizer on drug crystallinity of hydroxypropyl methylcellulose matrix film. Int J Biol Macromol. 2014;67:295–302.
  • Aleanizy FS, Alqahtani F, Gohary AO, Tahir EE, Shalabi RA. Determination and characterization of metronidazole–kaolin interaction. Saudi Pharm J. 23(2015):167–76.
  • Rausell-Colom J, Serratosa J. Chemistry of clays and clay minerals. In: Newman ACD, editor. Mineralogical society monograph. New York: Wiley Interscience; 1987.
  • Colombo P, Bettini R, Massimo G, Catellani PL, Santi P, Peppas NA. Drug diffusion front movement is important in drug release control from swellable matrix tablets. J Pharm Sci. 1995;84:991–97.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.